secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2021-09-13T23:59:59+00:00
Accession:  0001654954-21-009965
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma holds business teleconference on Sep 13, 2021; presentation slide content not disclosed
--------------------------------------------------------------------------------

- Company presented business overview via teleconference on September 13, 2021.
- Presentation filed as Exhibit 99.1 but no substantive financial or operational details were included in the 8-K.
- No earnings, guidance, or material events disclosed in the filing.
- The event appears to be a routine investor update; no specific facts available.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000165495421009965/0001654954-21-009965-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000165495421009965/gtbp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-21-009965

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer